CJC-1295

CJC-1295

From $60.00

A synthetic analog of growth hormone-releasing hormone (GHRH) studied for its ability to increase sustained growth hormone secretion through extended half-life. Supplied as a lyophilized powder for reconstitution.

For Research Use Only (RUO)

Technical Details

CAS Number863288-34-0
Molecular FormulaC152H252N44O42
Molecular Weight3367.97 g/mol
Purity≥99% HPLC
ClassificationRUO

About CJC-1295

CJC-1295 is a synthetic 30-amino acid peptide analog of growth hormone-releasing hormone (GHRH, also known as somatoliberin). It was developed through tetrasubstitution of the GHRH(1-29) sequence to improve metabolic stability and extend biological half-life. Research has demonstrated its ability to produce sustained elevations in growth hormone and IGF-1 levels in animal models without altering the natural pulsatile pattern of GH secretion.

Preclinical and early clinical investigations have examined CJC-1295's pharmacokinetic profile, dose-response characteristics, and potential effects on body composition, fat metabolism, and lean mass. Its extended duration of action compared to native GHRH has made it a valuable tool for studying the physiological consequences of prolonged GHRH receptor activation.

CJC-1295 is supplied as a lyophilized powder for research use only. Each lot is subjected to rigorous quality control testing, including sequence verification by mass spectrometry and purity determination by HPLC.